nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Muscular weakness—Fluorouracil—skin cancer	0.00185	0.00185	CcSEcCtD
Tobramycin—Nervous system disorder—Imiquimod—skin cancer	0.00183	0.00183	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Temozolomide—skin cancer	0.00183	0.00183	CcSEcCtD
Tobramycin—Skin disorder—Imiquimod—skin cancer	0.00182	0.00182	CcSEcCtD
Tobramycin—Agranulocytosis—Dactinomycin—skin cancer	0.00181	0.00181	CcSEcCtD
Tobramycin—Eosinophilia—Fluorouracil—skin cancer	0.0018	0.0018	CcSEcCtD
Tobramycin—Weight decreased—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Tobramycin—Anorexia—Imiquimod—skin cancer	0.00178	0.00178	CcSEcCtD
Tobramycin—Infestation NOS—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Tobramycin—Infestation—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Tobramycin—Thrombophlebitis—Docetaxel—skin cancer	0.00175	0.00175	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00174	0.00174	CcSEcCtD
Tobramycin—Body temperature increased—Vemurafenib—skin cancer	0.00173	0.00173	CcSEcCtD
Tobramycin—Pharyngitis—Dactinomycin—skin cancer	0.00173	0.00173	CcSEcCtD
Tobramycin—Neuropathy peripheral—Temozolomide—skin cancer	0.00172	0.00172	CcSEcCtD
Tobramycin—Swelling—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Tobramycin—Stomatitis—Temozolomide—skin cancer	0.00171	0.00171	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.0017	0.0017	CcSEcCtD
Tobramycin—Deafness—Docetaxel—skin cancer	0.0017	0.0017	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00169	0.00169	CcSEcCtD
Tobramycin—Paraesthesia—Imiquimod—skin cancer	0.00168	0.00168	CcSEcCtD
Tobramycin—Dyspnoea—Imiquimod—skin cancer	0.00167	0.00167	CcSEcCtD
Tobramycin—Sinusitis—Temozolomide—skin cancer	0.00165	0.00165	CcSEcCtD
Tobramycin—Erythema—Bleomycin—skin cancer	0.00163	0.00163	CcSEcCtD
Tobramycin—Decreased appetite—Imiquimod—skin cancer	0.00163	0.00163	CcSEcCtD
Tobramycin—Infestation NOS—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Tobramycin—Infestation—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Tobramycin—Hypersensitivity—Vemurafenib—skin cancer	0.00162	0.00162	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00162	0.00162	CcSEcCtD
Tobramycin—Pain—Imiquimod—skin cancer	0.0016	0.0016	CcSEcCtD
Tobramycin—Renal impairment—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Tobramycin—Neuropathy peripheral—Fluorouracil—skin cancer	0.00159	0.00159	CcSEcCtD
Tobramycin—Stomatitis—Fluorouracil—skin cancer	0.00158	0.00158	CcSEcCtD
Tobramycin—Asthenia—Vemurafenib—skin cancer	0.00157	0.00157	CcSEcCtD
Tobramycin—Pharyngitis—Temozolomide—skin cancer	0.00157	0.00157	CcSEcCtD
Tobramycin—Urinary tract disorder—Temozolomide—skin cancer	0.00156	0.00156	CcSEcCtD
Tobramycin—Pruritus—Vemurafenib—skin cancer	0.00155	0.00155	CcSEcCtD
Tobramycin—Connective tissue disorder—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Tobramycin—Lethargy—Docetaxel—skin cancer	0.00155	0.00155	CcSEcCtD
Tobramycin—Urethral disorder—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Tobramycin—Feeling abnormal—Imiquimod—skin cancer	0.00154	0.00154	CcSEcCtD
Tobramycin—Gastrointestinal pain—Imiquimod—skin cancer	0.00153	0.00153	CcSEcCtD
Tobramycin—Epistaxis—Fluorouracil—skin cancer	0.00153	0.00153	CcSEcCtD
Tobramycin—Visual impairment—Temozolomide—skin cancer	0.00152	0.00152	CcSEcCtD
Tobramycin—Sinusitis—Fluorouracil—skin cancer	0.00152	0.00152	CcSEcCtD
Tobramycin—Erythema—Dactinomycin—skin cancer	0.00152	0.00152	CcSEcCtD
Tobramycin—Agranulocytosis—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Tobramycin—Ill-defined disorder—Bleomycin—skin cancer	0.00151	0.00151	CcSEcCtD
Tobramycin—Anaemia—Bleomycin—skin cancer	0.00151	0.00151	CcSEcCtD
Tobramycin—Diarrhoea—Vemurafenib—skin cancer	0.0015	0.0015	CcSEcCtD
Tobramycin—Urticaria—Imiquimod—skin cancer	0.00149	0.00149	CcSEcCtD
Tobramycin—Abdominal pain—Imiquimod—skin cancer	0.00148	0.00148	CcSEcCtD
Tobramycin—Body temperature increased—Imiquimod—skin cancer	0.00148	0.00148	CcSEcCtD
Tobramycin—Eye disorder—Temozolomide—skin cancer	0.00147	0.00147	CcSEcCtD
Tobramycin—Tinnitus—Temozolomide—skin cancer	0.00147	0.00147	CcSEcCtD
Tobramycin—Malaise—Bleomycin—skin cancer	0.00147	0.00147	CcSEcCtD
Tobramycin—Leukopenia—Bleomycin—skin cancer	0.00146	0.00146	CcSEcCtD
Tobramycin—Rhinitis—Fluorouracil—skin cancer	0.00146	0.00146	CcSEcCtD
Tobramycin—Dizziness—Vemurafenib—skin cancer	0.00145	0.00145	CcSEcCtD
Tobramycin—Pharyngitis—Fluorouracil—skin cancer	0.00144	0.00144	CcSEcCtD
Tobramycin—Angiopathy—Temozolomide—skin cancer	0.00143	0.00143	CcSEcCtD
Tobramycin—Immune system disorder—Temozolomide—skin cancer	0.00143	0.00143	CcSEcCtD
Tobramycin—Mediastinal disorder—Temozolomide—skin cancer	0.00142	0.00142	CcSEcCtD
Tobramycin—Cough—Bleomycin—skin cancer	0.00142	0.00142	CcSEcCtD
Tobramycin—Dehydration—Docetaxel—skin cancer	0.00141	0.00141	CcSEcCtD
Tobramycin—Ill-defined disorder—Dactinomycin—skin cancer	0.00141	0.00141	CcSEcCtD
Tobramycin—Anaemia—Dactinomycin—skin cancer	0.0014	0.0014	CcSEcCtD
Tobramycin—Vomiting—Vemurafenib—skin cancer	0.00139	0.00139	CcSEcCtD
Tobramycin—Dry skin—Docetaxel—skin cancer	0.00139	0.00139	CcSEcCtD
Tobramycin—Chest pain—Bleomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Tobramycin—Myalgia—Bleomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Tobramycin—Rash—Vemurafenib—skin cancer	0.00138	0.00138	CcSEcCtD
Tobramycin—Dermatitis—Vemurafenib—skin cancer	0.00138	0.00138	CcSEcCtD
Tobramycin—Hypersensitivity—Imiquimod—skin cancer	0.00138	0.00138	CcSEcCtD
Tobramycin—Headache—Vemurafenib—skin cancer	0.00137	0.00137	CcSEcCtD
Tobramycin—Erythema—Temozolomide—skin cancer	0.00137	0.00137	CcSEcCtD
Tobramycin—Discomfort—Bleomycin—skin cancer	0.00137	0.00137	CcSEcCtD
Tobramycin—Malaise—Dactinomycin—skin cancer	0.00137	0.00137	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Tobramycin—Leukopenia—Dactinomycin—skin cancer	0.00136	0.00136	CcSEcCtD
Tobramycin—Dysgeusia—Temozolomide—skin cancer	0.00135	0.00135	CcSEcCtD
Tobramycin—Asthenia—Imiquimod—skin cancer	0.00134	0.00134	CcSEcCtD
Tobramycin—Confusional state—Bleomycin—skin cancer	0.00134	0.00134	CcSEcCtD
Tobramycin—Anaphylactic shock—Bleomycin—skin cancer	0.00133	0.00133	CcSEcCtD
Tobramycin—Back pain—Temozolomide—skin cancer	0.00133	0.00133	CcSEcCtD
Tobramycin—Pruritus—Imiquimod—skin cancer	0.00132	0.00132	CcSEcCtD
Tobramycin—Nausea—Vemurafenib—skin cancer	0.0013	0.0013	CcSEcCtD
Tobramycin—Thrombocytopenia—Bleomycin—skin cancer	0.0013	0.0013	CcSEcCtD
Tobramycin—Vision blurred—Temozolomide—skin cancer	0.00129	0.00129	CcSEcCtD
Tobramycin—Myalgia—Dactinomycin—skin cancer	0.00129	0.00129	CcSEcCtD
Tobramycin—Bronchospasm—Docetaxel—skin cancer	0.00129	0.00129	CcSEcCtD
Tobramycin—Diarrhoea—Imiquimod—skin cancer	0.00128	0.00128	CcSEcCtD
Tobramycin—Discomfort—Dactinomycin—skin cancer	0.00128	0.00128	CcSEcCtD
Tobramycin—Ill-defined disorder—Temozolomide—skin cancer	0.00127	0.00127	CcSEcCtD
Tobramycin—Anaemia—Temozolomide—skin cancer	0.00127	0.00127	CcSEcCtD
Tobramycin—Anorexia—Bleomycin—skin cancer	0.00127	0.00127	CcSEcCtD
Tobramycin—Erythema—Fluorouracil—skin cancer	0.00127	0.00127	CcSEcCtD
Tobramycin—Angioedema—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Tobramycin—Malaise—Temozolomide—skin cancer	0.00124	0.00124	CcSEcCtD
Tobramycin—Dizziness—Imiquimod—skin cancer	0.00124	0.00124	CcSEcCtD
Tobramycin—Vertigo—Temozolomide—skin cancer	0.00123	0.00123	CcSEcCtD
Tobramycin—Leukopenia—Temozolomide—skin cancer	0.00123	0.00123	CcSEcCtD
Tobramycin—Thrombocytopenia—Dactinomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Tobramycin—Cough—Temozolomide—skin cancer	0.0012	0.0012	CcSEcCtD
Tobramycin—Paraesthesia—Bleomycin—skin cancer	0.00119	0.00119	CcSEcCtD
Tobramycin—Vision blurred—Fluorouracil—skin cancer	0.00119	0.00119	CcSEcCtD
Tobramycin—Vomiting—Imiquimod—skin cancer	0.00119	0.00119	CcSEcCtD
Tobramycin—Weight decreased—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Tobramycin—Dyspnoea—Bleomycin—skin cancer	0.00118	0.00118	CcSEcCtD
Tobramycin—Anorexia—Dactinomycin—skin cancer	0.00118	0.00118	CcSEcCtD
Tobramycin—Rash—Imiquimod—skin cancer	0.00118	0.00118	CcSEcCtD
Tobramycin—Dermatitis—Imiquimod—skin cancer	0.00118	0.00118	CcSEcCtD
Tobramycin—Headache—Imiquimod—skin cancer	0.00117	0.00117	CcSEcCtD
Tobramycin—Anaemia—Fluorouracil—skin cancer	0.00117	0.00117	CcSEcCtD
Tobramycin—Myalgia—Temozolomide—skin cancer	0.00117	0.00117	CcSEcCtD
Tobramycin—Infestation NOS—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Tobramycin—Infestation—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00116	0.00116	CcSEcCtD
Tobramycin—Discomfort—Temozolomide—skin cancer	0.00116	0.00116	CcSEcCtD
Tobramycin—Decreased appetite—Bleomycin—skin cancer	0.00116	0.00116	CcSEcCtD
Tobramycin—Renal failure—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Tobramycin—Neuropathy peripheral—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Tobramycin—Stomatitis—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Tobramycin—Pain—Bleomycin—skin cancer	0.00114	0.00114	CcSEcCtD
Tobramycin—Leukopenia—Fluorouracil—skin cancer	0.00113	0.00113	CcSEcCtD
Tobramycin—Confusional state—Temozolomide—skin cancer	0.00113	0.00113	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00113	0.00113	CcSEcCtD
Tobramycin—Anaphylactic shock—Temozolomide—skin cancer	0.00112	0.00112	CcSEcCtD
Tobramycin—Nausea—Imiquimod—skin cancer	0.00111	0.00111	CcSEcCtD
Tobramycin—Epistaxis—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Tobramycin—Nervous system disorder—Temozolomide—skin cancer	0.0011	0.0011	CcSEcCtD
Tobramycin—Thrombocytopenia—Temozolomide—skin cancer	0.0011	0.0011	CcSEcCtD
Tobramycin—Feeling abnormal—Bleomycin—skin cancer	0.0011	0.0011	CcSEcCtD
Tobramycin—Agranulocytosis—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Tobramycin—Skin disorder—Temozolomide—skin cancer	0.00109	0.00109	CcSEcCtD
Tobramycin—Myalgia—Fluorouracil—skin cancer	0.00108	0.00108	CcSEcCtD
Tobramycin—Chest pain—Fluorouracil—skin cancer	0.00108	0.00108	CcSEcCtD
Tobramycin—Decreased appetite—Dactinomycin—skin cancer	0.00108	0.00108	CcSEcCtD
Tobramycin—Anorexia—Temozolomide—skin cancer	0.00107	0.00107	CcSEcCtD
Tobramycin—Discomfort—Fluorouracil—skin cancer	0.00106	0.00106	CcSEcCtD
Tobramycin—Pain—Dactinomycin—skin cancer	0.00106	0.00106	CcSEcCtD
Tobramycin—Urticaria—Bleomycin—skin cancer	0.00106	0.00106	CcSEcCtD
Tobramycin—Rhinitis—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Tobramycin—Body temperature increased—Bleomycin—skin cancer	0.00105	0.00105	CcSEcCtD
Tobramycin—Confusional state—Fluorouracil—skin cancer	0.00104	0.00104	CcSEcCtD
Tobramycin—Pharyngitis—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Tobramycin—Urinary tract disorder—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Tobramycin—Anaphylactic shock—Fluorouracil—skin cancer	0.00103	0.00103	CcSEcCtD
Tobramycin—Connective tissue disorder—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Tobramycin—Urethral disorder—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Tobramycin—Feeling abnormal—Dactinomycin—skin cancer	0.00102	0.00102	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00102	0.00102	CcSEcCtD
Tobramycin—Gastrointestinal pain—Dactinomycin—skin cancer	0.00101	0.00101	CcSEcCtD
Tobramycin—Nervous system disorder—Fluorouracil—skin cancer	0.00101	0.00101	CcSEcCtD
Tobramycin—Thrombocytopenia—Fluorouracil—skin cancer	0.00101	0.00101	CcSEcCtD
Tobramycin—Visual impairment—Docetaxel—skin cancer	0.00101	0.00101	CcSEcCtD
Tobramycin—Paraesthesia—Temozolomide—skin cancer	0.00101	0.00101	CcSEcCtD
Tobramycin—Dyspnoea—Temozolomide—skin cancer	0.001	0.001	CcSEcCtD
Tobramycin—Anorexia—Fluorouracil—skin cancer	0.000985	0.000985	CcSEcCtD
Tobramycin—Eye disorder—Docetaxel—skin cancer	0.000981	0.000981	CcSEcCtD
Tobramycin—Abdominal pain—Dactinomycin—skin cancer	0.00098	0.00098	CcSEcCtD
Tobramycin—Body temperature increased—Dactinomycin—skin cancer	0.00098	0.00098	CcSEcCtD
Tobramycin—Hypersensitivity—Bleomycin—skin cancer	0.000979	0.000979	CcSEcCtD
Tobramycin—Decreased appetite—Temozolomide—skin cancer	0.000975	0.000975	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000968	0.000968	CcSEcCtD
Tobramycin—Pain—Temozolomide—skin cancer	0.000959	0.000959	CcSEcCtD
Tobramycin—Asthenia—Bleomycin—skin cancer	0.000954	0.000954	CcSEcCtD
Tobramycin—Angiopathy—Docetaxel—skin cancer	0.000952	0.000952	CcSEcCtD
Tobramycin—Immune system disorder—Docetaxel—skin cancer	0.000948	0.000948	CcSEcCtD
Tobramycin—Mediastinal disorder—Docetaxel—skin cancer	0.000946	0.000946	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000941	0.000941	CcSEcCtD
Tobramycin—Pruritus—Bleomycin—skin cancer	0.00094	0.00094	CcSEcCtD
Tobramycin—Paraesthesia—Fluorouracil—skin cancer	0.000928	0.000928	CcSEcCtD
Tobramycin—Feeling abnormal—Temozolomide—skin cancer	0.000924	0.000924	CcSEcCtD
Tobramycin—Dyspnoea—Fluorouracil—skin cancer	0.000921	0.000921	CcSEcCtD
Tobramycin—Gastrointestinal pain—Temozolomide—skin cancer	0.000917	0.000917	CcSEcCtD
Tobramycin—Erythema—Docetaxel—skin cancer	0.000914	0.000914	CcSEcCtD
Tobramycin—Hypersensitivity—Dactinomycin—skin cancer	0.000913	0.000913	CcSEcCtD
Tobramycin—Decreased appetite—Fluorouracil—skin cancer	0.000898	0.000898	CcSEcCtD
Tobramycin—Dysgeusia—Docetaxel—skin cancer	0.000895	0.000895	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000892	0.000892	CcSEcCtD
Tobramycin—Urticaria—Temozolomide—skin cancer	0.000891	0.000891	CcSEcCtD
Tobramycin—Asthenia—Dactinomycin—skin cancer	0.000889	0.000889	CcSEcCtD
Tobramycin—Body temperature increased—Temozolomide—skin cancer	0.000886	0.000886	CcSEcCtD
Tobramycin—Abdominal pain—Temozolomide—skin cancer	0.000886	0.000886	CcSEcCtD
Tobramycin—Back pain—Docetaxel—skin cancer	0.000884	0.000884	CcSEcCtD
Tobramycin—Pain—Fluorouracil—skin cancer	0.000883	0.000883	CcSEcCtD
Tobramycin—Feeling abnormal—Fluorouracil—skin cancer	0.000851	0.000851	CcSEcCtD
Tobramycin—Diarrhoea—Dactinomycin—skin cancer	0.000848	0.000848	CcSEcCtD
Tobramycin—Vomiting—Bleomycin—skin cancer	0.000845	0.000845	CcSEcCtD
Tobramycin—Anaemia—Docetaxel—skin cancer	0.000844	0.000844	CcSEcCtD
Tobramycin—Rash—Bleomycin—skin cancer	0.000838	0.000838	CcSEcCtD
Tobramycin—Dermatitis—Bleomycin—skin cancer	0.000837	0.000837	CcSEcCtD
Tobramycin—Hypersensitivity—Temozolomide—skin cancer	0.000826	0.000826	CcSEcCtD
Tobramycin—Urticaria—Fluorouracil—skin cancer	0.000821	0.000821	CcSEcCtD
Tobramycin—Leukopenia—Docetaxel—skin cancer	0.000818	0.000818	CcSEcCtD
Tobramycin—Body temperature increased—Fluorouracil—skin cancer	0.000817	0.000817	CcSEcCtD
Tobramycin—Asthenia—Temozolomide—skin cancer	0.000804	0.000804	CcSEcCtD
Tobramycin—Cough—Docetaxel—skin cancer	0.000797	0.000797	CcSEcCtD
Tobramycin—Pruritus—Temozolomide—skin cancer	0.000793	0.000793	CcSEcCtD
Tobramycin—Nausea—Bleomycin—skin cancer	0.000789	0.000789	CcSEcCtD
Tobramycin—Vomiting—Dactinomycin—skin cancer	0.000788	0.000788	CcSEcCtD
Tobramycin—Rash—Dactinomycin—skin cancer	0.000782	0.000782	CcSEcCtD
Tobramycin—Chest pain—Docetaxel—skin cancer	0.000778	0.000778	CcSEcCtD
Tobramycin—Myalgia—Docetaxel—skin cancer	0.000778	0.000778	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000772	0.000772	CcSEcCtD
Tobramycin—Diarrhoea—Temozolomide—skin cancer	0.000767	0.000767	CcSEcCtD
Tobramycin—Hypersensitivity—Fluorouracil—skin cancer	0.000761	0.000761	CcSEcCtD
Tobramycin—Confusional state—Docetaxel—skin cancer	0.000752	0.000752	CcSEcCtD
Tobramycin—Anaphylactic shock—Docetaxel—skin cancer	0.000746	0.000746	CcSEcCtD
Tobramycin—Dizziness—Temozolomide—skin cancer	0.000741	0.000741	CcSEcCtD
Tobramycin—Nausea—Dactinomycin—skin cancer	0.000736	0.000736	CcSEcCtD
Tobramycin—Nervous system disorder—Docetaxel—skin cancer	0.000731	0.000731	CcSEcCtD
Tobramycin—Pruritus—Fluorouracil—skin cancer	0.000731	0.000731	CcSEcCtD
Tobramycin—Thrombocytopenia—Docetaxel—skin cancer	0.00073	0.00073	CcSEcCtD
Tobramycin—Skin disorder—Docetaxel—skin cancer	0.000724	0.000724	CcSEcCtD
Tobramycin—Vomiting—Temozolomide—skin cancer	0.000713	0.000713	CcSEcCtD
Tobramycin—Anorexia—Docetaxel—skin cancer	0.000711	0.000711	CcSEcCtD
Tobramycin—Rash—Temozolomide—skin cancer	0.000707	0.000707	CcSEcCtD
Tobramycin—Diarrhoea—Fluorouracil—skin cancer	0.000707	0.000707	CcSEcCtD
Tobramycin—Dermatitis—Temozolomide—skin cancer	0.000706	0.000706	CcSEcCtD
Tobramycin—Headache—Temozolomide—skin cancer	0.000702	0.000702	CcSEcCtD
Tobramycin—Dizziness—Fluorouracil—skin cancer	0.000683	0.000683	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000679	0.000679	CcSEcCtD
Tobramycin—Paraesthesia—Docetaxel—skin cancer	0.00067	0.00067	CcSEcCtD
Tobramycin—Nausea—Temozolomide—skin cancer	0.000666	0.000666	CcSEcCtD
Tobramycin—Dyspnoea—Docetaxel—skin cancer	0.000665	0.000665	CcSEcCtD
Tobramycin—Vomiting—Fluorouracil—skin cancer	0.000657	0.000657	CcSEcCtD
Tobramycin—Rash—Fluorouracil—skin cancer	0.000651	0.000651	CcSEcCtD
Tobramycin—Dermatitis—Fluorouracil—skin cancer	0.000651	0.000651	CcSEcCtD
Tobramycin—Decreased appetite—Docetaxel—skin cancer	0.000648	0.000648	CcSEcCtD
Tobramycin—Headache—Fluorouracil—skin cancer	0.000647	0.000647	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000644	0.000644	CcSEcCtD
Tobramycin—Pain—Docetaxel—skin cancer	0.000638	0.000638	CcSEcCtD
Tobramycin—Feeling abnormal—Docetaxel—skin cancer	0.000614	0.000614	CcSEcCtD
Tobramycin—Nausea—Fluorouracil—skin cancer	0.000614	0.000614	CcSEcCtD
Tobramycin—Gastrointestinal pain—Docetaxel—skin cancer	0.00061	0.00061	CcSEcCtD
Tobramycin—Abdominal pain—Docetaxel—skin cancer	0.000589	0.000589	CcSEcCtD
Tobramycin—Body temperature increased—Docetaxel—skin cancer	0.000589	0.000589	CcSEcCtD
Tobramycin—Hypersensitivity—Docetaxel—skin cancer	0.000549	0.000549	CcSEcCtD
Tobramycin—Asthenia—Docetaxel—skin cancer	0.000535	0.000535	CcSEcCtD
Tobramycin—Pruritus—Docetaxel—skin cancer	0.000528	0.000528	CcSEcCtD
Tobramycin—Diarrhoea—Docetaxel—skin cancer	0.00051	0.00051	CcSEcCtD
Tobramycin—Dizziness—Docetaxel—skin cancer	0.000493	0.000493	CcSEcCtD
Tobramycin—Vomiting—Docetaxel—skin cancer	0.000474	0.000474	CcSEcCtD
Tobramycin—Rash—Docetaxel—skin cancer	0.00047	0.00047	CcSEcCtD
Tobramycin—Dermatitis—Docetaxel—skin cancer	0.00047	0.00047	CcSEcCtD
Tobramycin—Headache—Docetaxel—skin cancer	0.000467	0.000467	CcSEcCtD
Tobramycin—Nausea—Docetaxel—skin cancer	0.000443	0.000443	CcSEcCtD
